Sodium taurodeoxycholate hydrate
CAS No. 207737-97-1
Sodium taurodeoxycholate hydrate ( Taurodeoxycholic acid sodium salt monohydrate )
产品货号. M23933 CAS No. 207737-97-1
牛磺脱氧胆酸钠水合物已用于评估胆汁盐亚胶束浓度对脂质双层膜的影响的研究。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 500MG | ¥340 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Sodium taurodeoxycholate hydrate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述牛磺脱氧胆酸钠水合物已用于评估胆汁盐亚胶束浓度对脂质双层膜的影响的研究。
-
产品描述Sodium taurodeoxycholate hydrate has been used in a study to assess the effect of submicellar concentrations of bile salts on the lipid bilayer membrane.
-
体外实验The median plasma concentration of Taurodeoxycholate is 33.9 nM in healthy individuals.Taurodeoxycholate inhibits the binding of N-3H-methylscopolamine to the M3 muscarinic receptor of acetylcholine with an IC50 of 170 μM.Taurodeoxycholate (0.05-1.00 mM; 1-6 days) stimulates intestinal epithelial cell proliferation.Taurodeoxycholate (0.05-1.00 mM; 24 h) induces a significant increase in S-phase concentration and a significant decrease in G1-phase concentration of the cell cycle, increases c-myc protein and mRNA expression in IEC-6 cells. Cell Proliferation Assay Cell Line:IEC-6 and caco-2 cells Concentration:0, 0.05, 0.50, and 1.00 mM Incubation Time:1, 2, 4 and 6 days Result:Significantly stimulated intestinal epithelial cell proliferation in a dose-dependent manner.Cell Cycle Analysis Cell Line:IEC-6 cells Concentration:0, 0.05, 0.50, and 1.00 mM Incubation Time:24 h Result:Significantly increased cells in S phase and decreased cells in G1-phase.Western Blot Analysis Cell Line:IEC-6 cells Concentration:0.5 mM Incubation Time:1 and 6 days Result:Significantly increased c-myc protein expression.
-
体内实验Taurodeoxycholate (0.5 mg/kg; i.v.; once) confers protection to C57BL/6N mice with sepsis, but does not protect TGR5 KO mice under sepsis. Animal Model:C57BL/6N mice, Lipopolysaccharides (HY-D1056) injection model of sepsisDosage:0.5 mg/kg Administration:Intravenous injection, 30 min or 24 h after LPS injection Result:Improved the survival rate of mice with sepsis. Decreased liver and kidney damage in septic mice. Ameliorated systemic inflammation and normalized blood pressure in septic mice.
-
同义词Taurodeoxycholic acid sodium salt monohydrate
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number207737-97-1
-
分子量539.7
-
分子式C26H44NO6S.Na.H2O
-
纯度>98% (HPLC)
-
溶解度In Vitro:?H2O : 100 mg/mL (191.68 mM)
-
SMILESC[C@H](CCC(NCCS(=O)([O-])=O)=O)[C@H]1CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C.[H]O[H].[Na+]
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Barbara, Orioni, Mauro, et al. Polymorphic Behavior in Protein?Surfactant Mixtures:? The Water?Bovine Serum Albumin?Sodium Taurodeoxycholate System[J]. Journal of Physical Chemistry B, 2006.
产品手册
关联产品
-
D-D-D-D-D-D
D-D-D-D-D-D
-
[Tyr1]-pTH (1-34) (r...
[Tyr1]-pTH (1-34) (rat)
-
[D-Arg2] Dermorphin ...
[D-Arg2]Dermorphin-(1-4) amide 是具有低温作用的 [D-Arg2]Dermorphin 的 N 端短肽酰胺。[D-Arg2]Dermorphin-(1-4) amide 在可溶性小鼠肝和脑提取物中显示镇痛活性和降解。
021-51111890
购物车()
sales@molnova.cn

